Alzheimer’s research, need for funding highlighted during Blunt visit

Alzheimer’s research, need for funding highlighted during Blunt visit

U.S. Sen. Roy Blunt, R-Mo., visited the Medical Campus this week to meet with physicians who treat patients with Alzheimer’s disease, and patients and caregivers who live with the debilitating disease every day. Blunt, pictured with physician-scientist Randall J. Bateman, chairs a subcommittee that oversees funding for medical research.

Four faculty recognized for their achievements

Four WUSTL faculty members were recognized for their accomplishments during the Faculty Achievement Awards ceremony Dec. 7 in Simon Hall. (From left) David M. Holtzman, MD, and Randall J. Bateman, MD, received the Chancellor’s Award for Innovation and Entrepreneurship Award from Chancellor Mark S. Wrighton. James V. Wertsch, PhD, and Richard H. Gelberman, MD, received the Arthur Holly Compton Faculty Achievement Award and the Carl and Gerty Cori Faculty Achievement Award, respectively.

Trial to test prevention of Alzheimer’s has begun​​

Finding ways to diagnose and treat Alzheimer’s disease has frustrated scientists and clinicians for decades. But now the battle has reached a potentially significant milestone: the launch of the first clinical trials to test whether giving new drug treatments before dementia can prevent Alzheimer’s. Shown are School of Medicine MDs and Alzheimer’s researchers Randall Bateman (left) and John C. Morris.

Alzheimer’s brain change measured in humans

Scientists at the School of Medicine have measured a significant and potentially pivotal difference between the brains of patients with an inherited form of Alzheimer’s disease and healthy family members who do not carry the mutation. Randall Bateman, MD, is the study’s senior author.

Washington People: Randall Bateman

Randall Bateman, MD, had no intention of becoming a doctor when he enrolled as an undergraduate at Washington University in St. Louis. As a faculty member at the School of Medicine since 2006, Bateman now focuses his research on Alzheimer’s disease.